Objective
colorectal neuroendocrine neoplasms, DSS, Cancer
CANCER
Edited by: Valentina Guarnotta, University of Palermo, ItalyReviewed by: Ziyi Zuo, First Affiliated Hospital of Wenzhou Medical University, China; Jinkui Wang, Children’s Hospital of Chongqing Medical University, China†These authors have contributed equally to this workThis article was submitted to Cancer Endocrinology, a section of the journal Frontiers in EndocrinologyThis study aimed to clarify the incidence trend of all-stage colorectal neuroendocrine neoplasms (CRNENs), overall survival (OS), and disease-specific survival (DSS) of patients with stage II-IV CRNENs, and to establish relevant nomograms for risk stratification.